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Auditory neuropathy spectrum disorder is a unique group of hearing dysfunctions characterized by preserved outer hair cell 
function and abnormal neural conduction of the auditory pathway. However, the pathogenic mechanism underlying this disor-
der is not clear. We therefore performed a systematic review of genetic mouse models with different gene mutations to provide 
a valuable tool for better understanding of the process and the possible molecular mechanisms. Of the 18 articles retrieved, 
nine met the required criteria. All biochemical, histological, and electrophysiological results were recorded for each of the 
mouse models, as was the transgenic technology. This review provides a summary of different mouse models that may play an 
important role in the diagnosis and management of auditory neuropathy spectrum disorder in the future. 
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Auditory neuropathy, also referred to as auditory neuropa-
thy spectrum disorder (ANSD), is a disorder that affects the 
speech perception ability. It is characterized by abnormal 
neural conduction in the auditory pathway, with preserva-
tion of outer hair cell function. The audiological examina-
tion indicates absent or abnormal auditory brainstem re-
sponses (ABR), and the presence of otoacoustic emissions 
(OAE) and/or cochlear microphonics (CM) (Matsunaga et al., 
2012; Norrix and Velenovsky, 2014; Starr et al., 1996). This 
is reportedly separate from sensorineural hearing loss, as 
patients who suffer from ANSD also tend to have difficulty 
with speech perception, which is not in balance with their 
hearing level. This is suggested by the dyssynchronous 
neural response, also referred to as auditory dyssynchrony 
(AD) (Vlastarakos et al., 2008). ANSD may originate with-
in the auditory nerve (postsynaptic), or the inner hair cells 
(IHCs) and their synapses with auditory nerve terminals 
(presynaptic) (Rance, 2005; Starr et al., 2000), and in cer-
tain situations may result from a combination of any of the 
locations. Because of this, it has been named “auditory 
neuropathy spectrum disorder” (Manchaiah et al., 2011), a 
confusing terminology. ANSD can appear as an isolated 
nonsyndromic disorder, or as a component of a syndrome, 
such as a group of motor and/or sensory neuropathies like 
Friedrich’s ataxia. Both acquired and congenital forms of 
ANSD could be caused by a genetic disorder or a number of 
other etiologies, such as an infection, toxic metabolic dam-
age, or even hypercholesterolemia (Vlastarakos et al., 
2008). However, the etiologic factors have not been identi-
fied in roughly 50% of patients (Santarelli, 2010). Thus, it is 
important to learn more about the pathogenic mechanisms 
to have a greater understanding of ANSD.  
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Genetic testing is rapidly evolving worldwide, and an in-
creasing number of genes have been found to be associated 
with ANSD. Mutations of DIAPH3 (AUNA1), OTOF, 
A1FM1 (AUNX1), PJVK, and even mitochondrial 12S 
rRNA have been identified. These have all been shown to 
be causal in isolated ANSD. On the other hand, mutations 
such as PMP22, OPA1, NF-L, MPZ, GJB1, and TMEM- 
126A have been shown to be causal in syndromic ANSD 
(Zhang and Wang, 2014; Zong et al., 2015). Identical ANSD 
genes in animal models enable exploration of gene function 
and the pathogenesis of this disorder.  
Meanwhile, there is significant similarity between the 
mouse and human inner ear structures, making the mouse an 
appropriate animal model (Moser et al., 2013; Pennacchio, 
2003). To date, several mouse strains have been inbred to 
demonstrate hearing ability and the onset of hearing loss 
(Jones et al., 2006; Zheng et al., 1999); an example is the 
C57BL/6J (B6) strain, a popular mouse model of age-  
related hearing loss. Studies often use this strain for re-
search on sensorineural hearing loss in progressive aging. 
Critical hearing loss can be observed at just nine to twelve 
months of age. 
In addition, the organ of Corti has three rows of outer 
hair cells (OHCs) and just one row of IHCs. The apical sur-
faces of both of these are sensitive and have several dozen 
stereocilia. Moreover, the mouse models enable ultrastruc-
tural and histopathological research, and electrophysiologi-
cal measurements can be studied (Kikkawa et al., 2012). 
Because of this, the fine line that separates mouse and hu-
man genetics can be of use in the study of genes that are 
already known to cause deafness. We reviewed the genetic 
mouse models of ANSD, a research field that has experi-
enced remarkable advances in the last few years. 
RESULTS 
Description of the transgenic mouse models in the 
studies 
A total of 18 articles were found in the search; however, 
after comparing the criteria, only nine were used in the sys-
tematic review. Figure 1 shows the flow diagram.  
Table 1 reviews the characteristics that were identified in 
the studies, according to the publication time. Eight of the 
nine studies examined various deafness genes and their 
functions using transgenic animal models. The remaining 
study (May et al., 2011) examined the relationship between 
noise-induced auditory neuropathy and the medial olivo-
cochlear system, instead of a specific ANSD gene. In addi-
tion, studies on many different mouse strains were identi-
fied, including one on the C57 mouse, another on the 
129/Sv mouse, and one each on BALB/c and FVB/NJ 
mouse strains. In addition, two studies mixed 129 and C57 
strains, one combined 129/Sv with FVBn, one mixed CBA 
and 129, and one used an unknown strain. 
 
Figure 1  Flow chart of the systematic review. 
For the majority of studies, transgenic technologies gave 
way to knockout mouse models and led to further study 
with the phenotype; only one of the studies used a knock-in 
mouse (Delmaghani et al., 2006), in which DNA was in-
jected into fertilized eggs in order to create transgenic mice. 
The knockout mice had been created by inserting a targeted 
and modified non-working gene into embryonic stem cells 
of the mouse. Selections of clones were then integrated into 
the genome by homologous recombination. This allowed 
the takeover of wild type alleles. The embryonic stem cells 
were then usable for generating chimeric mice; over time, 
the mice began to host the allele that was targeted within the 
germline. This was done within a homozygous or heterozy-
gous state (Thomas and Capecchi, 1987). The use of the 
Cre/loxP recombinase system was the best method for gen-
erating knockouts. Using the gene targeting approach de-
scribed above, knock-in mice that were different from 
knockout mice could be generated by introducing a certain 
variant into the targeting vector. 
Risk of bias and study quality 
Figure 2 shows the results of the risk of bias assessment of 
the nine different studies in the systematic review. Consid-
ered the unique characteristics of the processes by which 
transgenic mice had been created, the random selection of 
experimental animals and observed indicators could not be 
completed. Therefore, the study quality was assessed using 
five items, including animal welfare. Figure 2 shows that 
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Table 1  Details of transgenic mice in the every studya) 
NO. Gene Mouse strain Types Technology Time 
1 Cx29 BALB/c KO* Western blotting, immunofluorescent labeling, 
electron-microscopic scan 
2006.2 (Tang et al.,  
2006) 
2 Slc19a2 129S4/SvJae KO 3D neurolucida software, cytocochleogram 2006.3 (Liberman et al., 
2006) 
3 Pjvk mixed C57BL/6-129/Sv KI* Morphology, immunofluorescence analyses, 
immunocytofluorescence 
2006.7 (Delmaghani et al.,
 2006) 
4 Otof mixed C57BL/6-129/SvPas KO  Immunohistofluorescence, Electron microscopy, 
Immunoblotting and immunoprecipitation, 
2006.10 (Roux et al.,  
2006) 
5 Slitrk6  C57BL/6J KO In situ hybridization, immunohistochemistry, Southern  
blot, RT-PCR,RT-PCR 
2009 (Katayama et al.,  
2009) 
6 nACh α9 mixed129/Sv-CBA/CaJ KO Electrophysiological methods 2011.12 (May et al., 2011)
7 Cx32 unknown KO Western Blot, immunofluorescent staining, 
epifluorescent microscopy 
2011.09 (B.D. et al., 2011)
8 Diaph3 FVB/NJ Transgenesis for  
diap3-overpressing 
SEM, immunohistochemistry, quantitative reverse  
transcription PCR (qRT-PCR) 
2013.2 (Schoen et al.,  
2013) 
9 Foxo3 mixed FVBn-129Sv KO 3D modeling, quantitative PCR, Western analysis, and  
immunofluorescence, histological techniques 
2013.10 (Gilels et al.,  
2013) 
a) KO*, knock-out mice; KI*, knock-in mice.  
 
Figure 2  Risk of bias, score (%) per risk of bias item. 
88.89% of the research produced a similar baseline, which 
can be explained by the background of the mice or the con-
ditions of the control group. However, most of the nine 
studies did not provide a randomized method. A majority 
also failed to state whether the allocation had been con-
cealed adequately, showing room for improved research. 
Audiological evaluations and inner ear morphology 
Even though each mouse had been studied for a different 
gene, nearly all had hearing loss. The overall design of the 
organ of Corti was monitored in many of the studies in or-
der to gain a deeper understanding of the cause of ANSD. 
No abnormal morphology within the organ of Corti was 
recorded; however, the spiral ganglion neurons (SGN) and 
hair cells often showed abnormalities. The functions     
of OHC could be reviewed with the measurement of distor-
tion product otoacoustic emissions/otoacoustic emissions 
(DPOAE/OAE); with ABR, the auditory neuropathy and 
IHC could also be assessed. The differences between the 
auditory functional structures varied based on the different 
gene mutations used, and nearly all the ABR’s largely var-
ied between experimental mice and control groups, as 
shown in Table 2. 
Experiment methods and possible pathogenesis 
Table 1 shows that molecular biological techniques, im-
munohistochemistry, and scanning electron microscopy 
(SEM) were commonly used for experimentation on mice. 
These techniques helped reveal the possible pathogenesis 
underlying ANSD, as analyzed in Table 2. This enabled us 
to conclude that ANSD pathogenesis can originate in any 
location, ranging from auditory neurons to IHCs. 
DISCUSSION  
Within the past 10 years, many genes associated with the 
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Table 2  Studies of morphology, audiological evaluations and the pathogenesisa) 
NO. 
Morphology Audiometry 
Pathogenesis of ANSD 
Corti SGN IHC OHC ABR DPOAE/OAE 
1 N demyelin N N A N Severe demyelination at SGN soma 




small threshold  
shift# 
IHC absence 
3 N N N N A N Neurons dysfunction along auditory path-
way 
4 N N N N A N Exocytosis in IHC abolished 
5 N loss N N NM NM SGN loss 
6 NM NM N N A N Noise promotes ANSD by altering the func-
tional maturation of the brain’s temporal 
pathways 
7 N N N N A NM Cochlear homeostasis dysregulation 
8 N N abnormal stere- 
ocilia ribbon 
synapses loss 
N A threshold in- 
creased(line 771) 
Abnormalities stereocilia of IHC and ribbon 
synapses loss 
9 N N A N A N Synaptic localization altered 
a) SGN, spiral ganglion neurons; IHC, inner hair cell; OHC, outer hair cell; ABR, auditory brainstem responses; DPOAE/OAE, distortion product otoa-
coustic emissions/otoacoustic emissions; N, normal; A, abnormality; NM, not mention; #, low-thiamine diet. 
pathogenesis of ANSD have been identified; thus, both 
postsynaptic and presynaptic ANSD have added to a clearer 
understanding of the disorder and its diagnosis. The studies 
covered eight different genes that helped identify the man-
ner in which they were connected to the pathology of audi-
tory neuropathy. These included Cx32, Cx29, SLC19A2, 
DIAPH3, SLITRK6, OTOF, PJVK, and FOXO3. Each of 
these can be identified as part of the isolated PJVK, 
DIAPH3, and OTOF genes, as well as the remaining 
non-isolated genes involved in multisystemic disorders with 
optic and peripheral neuropathies. One of the studies 
showed impairments within the medial olivocochlear sys-
tem, with an increased risk of environmentally introduced 
AN, rather than focusing on a particular gene. 
Table 2 schematically illustrates all possible underlying 
pathophysiological mechanisms in ANSD among the vari-
ous mouse models. Based on normal physiological process-
es in the cochlear, the temporal precision of acoustic sig-
naling can be related to rapid synaptic release and the acti-
vation of the postsynaptic membrane, as well as propagation 
along the auditory nerve fibers (Santarelli, 2010). If any of 
the presynaptic mechanisms get disrupted, it can cause the 
precession to be off with the temporal coding. This could 
also interfere with the reliability of synaptic transmissions, 
which could lead to ANSD (McMahon et al., 2008). An 
example of a typical presynaptic disorder that leads to 
ANSD is abnormal exocytosis in OTOF mutations (Roux  
et al., 2006). There can also be abnormal functioning in the 
IHC stereocilia caused by SLC19A2 (Liberman et al., 2006), 
FOXO3 (Gilels et al., 2013), and DIAPH3 (Schoen et al., 
2013) genes. At the same time, auditory nerve fibers and 
postsynaptic membranes adapt to provide quick and precise 
signal transmission (Santarelli, 2010). However, the 
knockout mouse Slitrk6 (Katayama et al., 2009) had 50% 
fewer SGN, with a reduced number of axon projections to 
cochlear hair cells. 
The auditory SGN with demyelination represented an-
other possible postsynaptic mechanism. This, however, is 
expected to reduce the speed of conduction when there is 
disruption of temporal coding (dyssynchrony) (Santarelli, 
2010; Zeng et al., 2005). A reduction of nerve fiber num-
bers located in the axonal neuropathies resulted in a lower 
auditory input within the brain stem. It is likely the patho-
physiology and demyelinating mechanism of ANSD in the 
mice lacking Cx29 gene (Tang et al., 2006). 
Oddly enough, the PJVK transgenic mice did not show 
any abnormalities (Delmaghani et al., 2006), but one study 
did strongly suggest that a primary lesion within DNB59 
and impaired hearing do not originate within the cochlear. 
Alternatively, the information suggested that a dysfunction 
took place within the neurons of the auditory pathway, and 
this coincided with an observation of the distribution of 
pejvakin within the bodies of SGN and brainstem auditory 
nuclei (Delmaghani et al., 2006). Additionally, research 
from Johns Hopkins (May et al., 2011) showed that noise 
promotes ANSD by altering maturation in the brain’s tem-
poral pathway. This has given rise to analytic findings from 
mouse models, like those in this study, and should help ex-
plain heterogeneity and its causes. 
Due to the lack of accurate tests for diagnosing dysfunc-
tion and the large range of outcomes, ANSD is often con-
fusing and difficult to diagnose. Audiological function can 
sometimes be examined by use of physiological tools (Gi-
raudet and Avan, 2012; Korver et al., 2012), which are 
helpful for CM, OAE, and ABR. The integrity of OHC may 
be determined by testing OAE. However, audiological tools 
used to examine the function of the afferent pathway, from 
the IHC to cranial nerve VIII, cannot identify the exact site 
of dysfunction (Norrix and Velenovsky, 2014). Thus, it is 
not possible to completely isolate IHC loss from synaptic 
dysfunction or neural hearing loss (axonal loss or dyssyn-
chrony due to demyelination) based on physiologic tests. 
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The studies used 3-dimensional models created using multi-
ple techniques. One study model provided data on the nu-
cleus, stereocilia, and IHC changes. In particular, the other 
provided a reconstruction of synaptic sections, which were 
used to determine the distribution quantity and synaptic 
numbers. 
Research on mice with hereditary hearing loss has helped 
identify dozens of different genes, along with the encoded 
proteins that are important for both development and 
maintenance of normal hearing. ANSD-related gene func-
tion in connection with typical electrophysiological patterns 
was obtained by comparing research with the findings of  
Table 3  Search strategy 
Search NO. Search details 
1 (“Auditory neuropathy” [Supplementary Concept] OR “Auditory neuropathy” [All Fields] OR “auditory neuropathy” [All Fields]) OR 
((“Auditory neuropathy” [Supplementary Concept] OR “Auditory neuropathy” [All Fields] OR “auditory neuropathy” [All Fields]) AND 
(“Spectrum” [Journal] OR “spectrum” [All Fields] OR “IEEE Spectr” [Journal] OR “spectrum” [All Fields]) AND (“disease” [MeSH 
Terms] OR “disease” [All Fields] OR “disorder” [All Fields])) OR (“Auditory neuropathy” [Supplementary Concept] OR “Auditory neu-
ropathy” [All Fields] OR “auditory dys synchrony” [All Fields]) 
2 “mice” [MeSH Terms] OR “mice” [All Fields] OR “mouse” [All Fields] 
3 genetic [All Fields] OR genetic’ [All Fields] OR genetic’a [All Fields] OR genetic’s [All Fields] OR genetic87 [All Fields] OR genetica
[All Fields] OR genetica1 [All Fields] OR genetica2008 [All Fields] OR geneticae [All Fields] OR geneticaily [All Fields] OR geneticain-
stituto [All Fields] OR genetical [All Fields] OR geneticalaboratorio [All Fields] OR geneticall [All Fields] OR geneticalliance [All Fields] 
OR genetically [All Fields] OR geneticallvery [All Fields] OR genetically [All Fields] OR genetically’ [All Fields] OR geneticallyspeaking
[All Fields] OR genetically [All Fields] OR geneticamed [All Fields] OR geneticamedica [All Fields] OR geneticamente [All Fields] OR 
geneticas [All Fields] OR geneticassays [All Fields] OR geneticay [All Fields] OR geneticbala [All Fields] OR genetic [All Fields] OR 
geneticchemistry [All Fields] OR geneticcmedicine [All Fields] OR geneticcomponent [All Fields] OR geneticcounseling [All Fields] OR 
geneticdiagnosis [All Fields] OR geneticdiversity [All Fields] OR genetice [All Fields] OR geneticepi [All Fields] OR geneticepidemiology
[All Fields] OR genetiche [All Fields] OR geneticheho [All Fields] OR genetichekii [All Fields] OR genetichekoe [All Fields] OR genet-
ichen [All Fields] OR geneticheskaia [All Fields] OR geneticheski [All Fields] OR geneticheski’I [All Fields] OR geneticheskie [All 
Fields] OR geneticheskih [All Fields] OR geneticheskii [All Fields] OR geneticheskikh [All Fields] OR geneticheskikih [All Fields] OR 
geneticheskim [All Fields] OR geneticheskimi [All Fields] OR genetichesko [All Fields] OR geneticheskoe [All Fields] OR genetich-
eskoekartirovanie [All Fields] OR geneticheskogo [All Fields] OR geneticheskoi [All Fields] OR geneticheskoi’ [All Fields] OR genetich-
eskom [All Fields] OR geneticheskomu [All Fields] OR geneticheskoo [All Fields] OR geneticheskor [All Fields] OR geneticheskuiu [All 
Fields] OR genetichestkikh [All Fields] OR genetichna [All Fields] OR genetichne [All Fields] OR genetichni [All Fields] OR genetichniia
[All Fields] OR genetichniiat [All Fields] OR genetichnite [All Fields] OR genetichno [All Fields] OR genetichnoto [All Fields] OR genet-
ichskaia [All Fields] OR genetichski [All Fields] OR genetichskikh [All Fields] OR genetichskoi [All Fields] OR genetici [All Fields] OR 
genetician [All Fields] OR geneticians [All Fields] OR geneticica [All Fields] OR geneticien [All Fields] OR geneticiens [All Fields] OR 
geneticii [All Fields] OR geneticimmunity [All Fields] OR geneticin [All Fields] OR geneticine [All Fields] OR geneticinstability [All 
Fields] OR geneticinterpred [All Fields] OR geneticisation [All Fields] OR geneticisation’ [All Fields] OR geneticised [All Fields] OR 
geneticism [All Fields] OR geneticist [All Fields] OR geneticist’s [All Fields] OR geneticista [All Fields] OR geneticistas [All Fields] OR 
geneticists [All Fields] OR geneticists’ [All Fields] OR geneticization [All Fields] OR geneticization’ [All Fields] OR geneticized [All 
Fields] OR geneticizing [All Fields] OR geneticjeskaia [All Fields] OR genetick [All Fields] OR genetick’a [All Fields] OR genetick’e [All 
Fields] OR genetick’eho [All Fields] OR geneticka [All Fields] OR genetickarthick [All Fields] OR geneticke [All Fields] OR genetickeho
[All Fields] OR genetickehskaia [All Fields] OR genetickej [All Fields] OR genetickem [All Fields] OR genetickemu [All Fields] OR 
genetickeskie [All Fields] OR genetickeskoi [All Fields] OR geneticki [All Fields] OR genetickie [All Fields] OR genetickih [All Fields] 
OR genetickim [All Fields] OR geneticko [All Fields] OR genetickog [All Fields] OR genetickou [All Fields] OR geneticku [All Fields] 
OR geneticky [All Fields] OR genetickych [All Fields] OR genetickym [All Fields] OR genetickymi [All Fields] OR geneticlab [All 
Fields] OR genetically [All Fields] OR geneticlmetabolic [All Fields] OR geneticly [All Fields] OR geneticmap [All Fields] OR ge-
neticmarkers [All Fields] OR geneticmedicine [All Fields] OR geneticmedicine1 [All Fields] OR geneticmedizin [All Fields] OR genetic-
medlabsprofdrfarsch [All Fields] OR geneticmouse [All Fields] OR geneticne [All Fields] OR geneticneskie [All Fields] OR geneticnet-
works [All Fields] OR genetico [All Fields] OR geneticobiochemical [All Fields] OR geneticoclinicas[All Fields] OR geneticoconstituci-
onal[All Fields] OR geneticoconstitutional [All Fields] OR geneticocytological [All Fields] OR geneticodispersion [All Fields] OR geneti-
coepidemiologic [All Fields] OR geneticoepidemiological [All Fields] OR geneticomathematic [All Fields] OR geneticomathematical [All 
Fields] OR geneticopathology [All Fields] OR geneticopatie [All Fields] OR geneticoracial [All Fields] OR geneticorpharmacological [All 
Fields] OR geneticos [All Fields] OR geneticoviral [All Fields] OR geneticpcr [All Fields] OR geneticpolymorphisms [All Fields] OR 
geneticreasons [All Fields] OR geneticreport111199 [All Fields] OR geneticresearch [All Fields] OR genetics [All Fields] OR genetics’
[All Fields] OR genetics’s [All Fields] OR genetics’ [All Fields] OR genetics106 [All Fields] OR genetics161 [All Fields] OR genet-
ics2007 [All Fields] OR genetics2011 [All Fields] OR genetics61 [All Fields] OR geneticsand [All Fields] OR geneticsandsociety [All 
Fields] OR geneticsbreeding [All Fields] OR geneticsby [All Fields] OR geneticscal [All Fields] OR geneticscenter [All Fields] OR genet-
icscentralcal [All Fields] OR geneticsdepartment [All Fields] OR geneticsdepartments [All Fields] OR geneticsdicle [All Fields] OR ge-
neticsdiv [All Fields] OR geneticseducation [All Fields] OR geneticsepidemiology [All Fields] OR geneticseunice [All Fields] OR genet-
icsfaculty [All Fields] OR geneticsfeinstein [All Fields] OR geneticsgynecology [All Fields] OR geneticshopital [All Fields] OR genet-
icsjulius [All Fields] OR geneticsm [All Fields] OR geneticsman [All Fields] OR geneticsmanitoba [All Fields] OR geneticsmedical [All 
Fields] OR geneticsmetabolism [All Fields] OR geneticsnathan [All Fields] OR geneticsnational [All Fields] OR geneticsof [All Fields] 
OR geneticsprogram [All Fields] OR geneticss [All Fields] OR geneticsshanghai [All Fields] OR geneticsshki [All Fields] OR geneticsstate
[All Fields] OR geneticstatistical [All Fields] OR geneticstudio [All Fields] OR geneticsuniversity [All Fields] OR geneticsy [All Fields] 
OR geneticsynth [All Fields] OR genetictechnologies [All Fields] OR geneticus [All Fields] OR geneticxchange [All Fields] OR geneticzs
[All Fields]) OR (“genes” [MeSH Terms] OR “genes” [All Fields] OR “gene” [All Fields] 
4 1 and 2 and 3 
5 limits: publication from January 1996 to May 2015, all languages 
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mouse models. This could be a key point in revealing how 
different molecular processes and their failures underlie 
ANSD.  
This study has several limitations. Systematic reviews 
are vulnerable to a variety of biases (Hirst et al., 2014). The 
quality of the transgenic mouse studies on ANSD was poor, 
because the small number of studies avoided performance, 
detection, and reporting bias, which highlights the require-
ment for animal research to reduce the risk of biased results 
and improve translatability in the future. 
METHODS 
Literature search 
The EMBASE and PubMed databases were used for a liter-
ature review as they provided articles published between 
1996 and 2015. As the first report of auditory neuropathy 
was in 1996, this was the initial point of the time frame. The 
plan for research was to locate information using Medical 
Subject Headings (MeSH) terms and keywords such as 
“gene,” “mouse,” and “auditory disease,” along with syno-
nyms for each in PubMed, as shown in Table 3. Then, simi-
lar terms were searched with EMBASE. In addition, the 
reference citations were also retrieved in order to further 
research and locate other articles related to the study. All 
work was done by just three researchers, working inde-
pendently. 
Study selection 
The inclusion criteria were as follows: (i) original articles; 
(ii) articles that contained information on mouse model ge-
netics and disorders directly or indirectly related to auditory 
issues; (iii) connections between ANSD pathogenesis and 
mouse models; (iv) only recently published information or 
completed data were used in the study. Discussions were 
held to identify differences between selections. A relevant 
article would be selected by one of the researchers, then 
passed to a second researcher who would check it against an 
original article. A meta-analysis was not possible because of 
heterogeneity in the mouse models. Figure 1 shows the flow 
chart and process of the reviews. 
Data extraction 
Information extracted from each of the studies included 
transgenic technology, animal strain, types of ANSD-related 
genes, details of outcome measurements (such as biochem-
ical, electrophysiological, and histological outcomes), and 
even pathogenic mechanisms. These items were recorded 
for every study. 
A 5-item checklist was used to help assess methodologi-
cal quality related to the animal models, using SYRCLE’s 
risk of bias tool (Hooijmans et al., 2014). The quality 
checks for all studies were done by three investigators 
working independently. Any disagreements were discussed 
and resolved. The biochemical, electrophysiological, and 
histological outcomes differed greatly; as a result, they 
could not be placed into categories and were reported sepa-
rately. 
Compliance and ethics  The author(s) declare that they have no conflict 
of interest. 
Acknowledgements  We are grateful to the professors of the Chinese 
PLA Institute of Otolaryngology for their support and encouragement. This 
work was supported by the National Key Basic Research Program of Chi-
na (2014CB943001), and the National Natural Science Foundation of 
China (81120108009, 81530032). 
Delmaghani, S., del Castillo, F.J., Michel, V., Leibovici, M., Aghaie, A., 
Ron, U., Van Laer, L., Ben-Tal, N., Van Camp, G., Weil, D., Langa, F., 
Lathrop, M., Avan, P., and Petit, C. (2006). Mutations in the gene en-
coding pejvakin, a newly identified protein of the afferent auditory 
pathway, cause DFNB59 auditory neuropathy. Nat Genet 38, 770–778. 
Gibson, B.D., Sollas, A., Mattiace, L.A., Yu, G.P., and Kim, A.H. (2011). 
Role of Connexin 32 (Cx32) and Hearing Loss In Charcot-Marie-Tooth 
Syndrome (CMTS) A. Laryngoscope 121(Supplement 5), S321. 
Gilels, F., Paquette, S.T., Zhang, J., Rahman, I., and White, P.M. (2013). 
Mutation of Foxo3 causes adult onset auditory neuropathy and alters 
cochlear synapse architecture in mice. J Neurosci 33, 18409–18424. 
Giraudet, F., and Avan, P. (2012). Auditory neuropathies: understanding 
their pathogenesis to illuminate intervention strategies. Curr Opin Neu-
rol 25, 50–56. 
Hirst, J.A., Howick, J., Aronson, J.K., Roberts, N., Perera, R., Koshiaris, 
C., and Heneghan, C. (2014). The need for randomization in animal tri-
als: an overview of systematic reviews. PLoS One 9, e98856. 
Hooijmans, C.R., Rovers, M.M., de Vries, R.B., Leenaars, M., 
Ritskes-Hoitinga, M., and Langendam, M.W. (2014). SYRCLE’s risk 
of bias tool for animal studies. BMC Med Res Methodol 14, 43. 
Jones, S.M., Jones, T.A., Johnson, K.R., Yu, H., Erway, L.C., and Zheng, 
Q.Y. (2006). A comparison of vestibular and auditory phenotypes in 
inbred mouse strains. Brain Res 1091, 40–46. 
Katayama, K., Zine, A., Ota, M., Matsumoto, Y., Inoue, T., Fritzsch, B., 
and Aruga, J. (2009). Disorganized innervation and neuronal loss in the 
inner ear of Slitrk6-deficient mice. PLoS One 4, e7786. 
Kikkawa, Y., Seki, Y., Okumura, K., Ohshiba, Y., Miyasaka, Y., Suzuki, 
S., Ozaki, M., Matsuoka, K., Noguchi, Y., and Yonekawa, H. (2012). 
Advantages of a mouse model for human hearing impairment. Exp 
Anim 61, 85–98. 
Korver, A.M., van Zanten, G.A., Meuwese-Jongejeugd, A., van Straaten, 
H.L., and Oudesluys-Murphy, A.M. (2012). Auditory neuropathy in a 
low-risk population: a review of the literature. Int J Pediatr Otorhino-
laryngol 76, 1708–1711. 
Liberman, M.C., Tartaglini, E., Fleming, J.C., and Neufeld, E.J. (2006). 
Deletion of SLC19A2, the high affinity thiamine transporter, causes se-
lective inner hair cell loss and an auditory neuropathy phenotype. J As-
soc Res Otolaryngol 7, 211–217. 
Manchaiah, V.K., Zhao, F., Danesh, A.A., and Duprey, R. (2011). The 
genetic basis of auditory neuropathy spectrum disorder (ANSD). Int J 
Pediatr Otorhinolaryngol 75, 151–158. 
Matsunaga, T., Mutai, H., Kunishima, S., Namba, K., Morimoto, N., Shin-
jo, Y., Arimoto, Y., Kataoka, Y., Shintani, T., Morita, N., Sugiuchi, T., 
Masuda, S., Nakano, A., Taiji, H., and Kaga, K. (2012). A prevalent 
founder mutation and genotype-phenotype correlations of OTOF in 
Japanese patients with auditory neuropathy. Clin Genet 82, 425–432. 
May, B.J., Lauer, A.M., and Roos, M.J. (2011). Impairments of the medial 
olivocochlear system increase the risk of noise-induced auditory neu-
ropathy in laboratory mice. Otol Neurotol 32, 1568–1578. 
McMahon, C.M., Patuzzi, R.B., Gibson, W.P., and Sanli, H. (2008). Fre-
486 Wang, L., et al.   Sci China Life Sci   May (2016) Vol.59 No.5 
quency-specific electrocochleography indicates that presynaptic and 
postsynaptic mechanisms of auditory neuropathy exist. Ear Hear 29, 
314–325. 
Moser, T., Predoehl, F., and Starr, A. (2013). Review of hair cell synapse 
defects in sensorineural hearing impairment. Otol Neurotol 34, 
995–1004. 
Norrix, L.W., and Velenovsky, D.S. (2014). Auditory neuropathy spectrum 
disorder: a review. J Speech Lang Hear Res 57, 1564–1576. 
Pennacchio, L.A. (2003). Insights from human/mouse genome compari-
sons. Mamm Genome 14, 429–436. 
Zhang, Q., and Wang, Q. (2014). Review of recent research progress in 
molecular genetic mechanism of auditory neuropathy spectrum disor-
der. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 49, 1040–1045. 
Rance, G. (2005). Auditory neuropathy/dys-synchrony and its perceptual 
consequences. Trends Amplif 9, 1–43. 
Roux, I., Safieddine, S., Nouvian, R., Grati, M., Simmler, M.C., Bahloul, 
A., Perfettini, I., Le Gall, M., Rostaing, P., Hamard, G., Triller, A., 
Avan, P., Moser, T., and Petit, C. (2006). Otoferlin, defective in a hu-
man deafness form, is essential for exocytosis at the auditory ribbon 
synapse. Cell 127, 277–289. 
Santarelli, R. (2010). Information from cochlear potentials and genetic 
mutations helps localize the lesion site in auditory neuropathy. Genome 
Med 2, 91. 
Schoen, C.J., Burmeister, M., and Lesperance, M.M. (2013). Diaphanous 
homolog 3 (Diap3) overexpression causes progressive hearing loss and 
inner hair cell defects in a transgenic mouse model of human deafness. 
PLoS One 8, e56520. 
Starr, A., Picton, T.W., Sininger, Y., Hood, L.J., and Berlin, C.I. (1996). 
Auditory neuropathy. Brain 119 ( Pt 3), 741–753. 
Starr, A., Sininger, Y.S., and Pratt, H. (2000). The varieties of auditory 
neuropathy. J Basic Clin Physiol Pharmacol 11, 215–230. 
Tang, W., Zhang, Y., Chang, Q., Ahmad, S., Dahlke, I., Yi, H., Chen, P., 
Paul, D.L., and Lin, X. (2006). Connexin29 is highly expressed in 
cochlear Schwann cells, and it is required for the normal development 
and function of the auditory nerve of mice. J Neurosci 26, 1991–1999. 
Thomas, K.R., and Capecchi, M.R. (1987). Site-directed mutagenesis by 
gene targeting in mouse embryo-derived stem cells. Cell 51, 503–512. 
Vlastarakos, P.V., Nikolopoulos, T.P., Tavoulari, E., Papacharalambous, 
G., and Korres, S. (2008). Auditory neuropathy: endocochlear lesion or 
temporal processing impairment? Implications for diagnosis and man-
agement. Int J Pediatr Otorhinolaryngol 72, 1135–1150. 
Zeng, F.G., Kong, Y.Y., Michalewski, H.J., and Starr, A. (2005). Percep-
tual consequences of disrupted auditory nerve activity. J Neurophysiol 
93, 3050–3063. 
Zheng, Q.Y., Johnson, K.R., and Erway, L.C. (1999). Assessment of hear-
ing in 80 inbred strains of mice by ABR threshold analyses. Hear Res 
130, 94–107. 
Zong, L., Guan, J., Ealy, M., Zhang, Q., Wang, D., Wang, H., Zhao, Y., 
Shen, Z., Campbell, C.A., Wang, F., Yang, J., Sun, W., Lan, L., Ding, 
D., Xie, L., Qi, Y., Lou, X., Huang, X., Shi, Q., Chang, S., Xiong, W., 
Yin, Z., Yu, N., Zhao, H., Wang, J., Wang, J., Salvi, R.J., Petit, C., 
Smith, R.J., and Wang, Q. (2015). Mutations in apoptosis-inducing 
factor cause X-linked recessive auditory neuropathy spectrum disorder. 
J Med Genet 52, 523–531. 
 
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
